Skip to content

Evidence

Latest FreedomWitness coverage in this editorial section.

Source briefing

Cancer Headlines With William Nelson

This month's topics include medical imaging and childhood cancers, low dose aspirin in colorectal cancer, AI and colonoscopy skills, and good news for women with early breast cancer.

Read →

Source briefing

Opinion/decision on a Paediatric investigation plan (PIP): Idefirix, imlifidase, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Renal and urinary disorders, PIP number: EMEA-002183-PIP03-23

Opinion/decision on a Paediatric investigation plan (PIP): Idefirix, imlifidase, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Renal and urinary disorders, PIP number: EMEA-002183-PIP03-23

Read →